These results are in contradiction with the data presented in the review by Soliman et al., who indicated the role of reduced miR-34a expression in the pathogenesis of MM by inhibiting cell apoptosis and stimulating pro-survival signaling by affecting CDK6, BCL2, TGIF2 and NOTCH1 [1]. The gene discussed is NOTCH1; the disease is Miyoshi myopathy.